McMorgan & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,863
Closed -$229K 42
2026
Q1
$229K Sell
3,863
-1,300
-25% -$84.3K 0.04% 32
2025
Q4
$319K Sell
5,163
-31,225
-86% -$1.91M 0.05% 30
2025
Q3
$2.27M Buy
36,388
+6,201
+21% +$432K 0.35% 33
2025
Q2
$2.41M Sell
30,187
-125
-0.4% -$10.5K 0.36% 34
2025
Q1
$2.61M Sell
30,312
-65
-0.2% -$5.33K 0.42% 33
2024
Q4
$2.37M Sell
30,377
-215
-0.7% -$16.7K 0.37% 38
2024
Q3
$2.21M Buy
30,592
+4,684
+18% +$332K 0.34% 37
2024
Q2
$1.78M Buy
+25,908
New +$1.76M 0.28% 40

Other funds holding PBH

McMorgan & Co's PBH Position: Q2 2026 in Review

McMorgan & Co sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 3,863 shares — an estimated $229K sold.

McMorgan & Co first reported a position in PBH in Q2 2024 and held it in 8 quarters. The position peaked at $2.61M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • McMorgan & Co reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • McMorgan & Co sold 3,863 Prestige Consumer Healthcare shares in Q2 2026, an estimated $229K.
  • McMorgan & Co first reported a position in Prestige Consumer Healthcare in Q2 2024 and held it in 8 quarters.
  • McMorgan & Co's Prestige Consumer Healthcare position peaked at $2.61M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on McMorgan & Co's 13F filing for Q2 2026, filed 14 Aug 2026.